Session Details

P018 Advancing Your Dermatologic Surgery Procedures and Practice

Sun, Jul 19, 8:45 AM - 10:45 AM
Sutton North
2 CME Available Parallel
View Map

DESCRIPTION

The performance of Mohs micrographic as well as dermatologic surgery has undergone substantive advances to simultaneously meet the evolving challenges for both the patient and the surgeon in performing excellent and successful surgery. This session will focus on innovative reconstructive approaches, minimally invasive nail biopsies and procedures, improving Mohs tissue processing, best surgery ergonomics, efficient scheduling and marketing as well as thoughtful ways to harness the power of application software for patient care.

LEARNING OBJECTIVES

1.

Choose innovative reconstructive surgical techniques to improve surgical care of patients.

2.

Develop ways to provide innovative and efficient patient care with best scheduling practices and upcoming software apps.

3.

Utilize optimized ergonomics and modern technology to perform Mohs and dermatologic surgery safely and efficiently.

SCHEDULE

8:45 AM

Discussion

DIRECTOR

Sumaira Zareen Aasi, MD, FAAD

Sumaira Zareen Aasi, MD, FAAD

SPEAKERS

Arif Aslam

Arif Aslam

Charlene Lam, MD, MPH, FAAD

Charlene Lam, MD, MPH, FAAD

Zakia Rahman, MD, FAAD

Zakia Rahman, MD, FAAD

Stanford University School of Medicine

Taha Rasul, MD

Taha Rasul, MD

Kathryn Shahwan, MD, FAAD

Kathryn Shahwan, MD, FAAD

The Ohio State University

Zain U. Syed, MD, FAAD

Zain U. Syed, MD, FAAD

Junqian Zhang, MD, FAAD

Junqian Zhang, MD, FAAD

Hospital of the University of Pennsylvania

DISCLOSURES

Sumaira Zareen Aasi, MD, FAAD

No financial relationships exist with ineligible companies.

Arif Aslam

No financial relationships exist with ineligible companies.

Charlene Lam, MD, MPH, FAAD

No financial relationships exist with ineligible companies.

Zakia Rahman, MD, FAAD

Allergan, Inc. – Advisory Board(Honoraria); Estee Lauder – Investigator(Grants/Research Funding);

Taha Rasul, MD

No financial relationships exist with ineligible companies.

Kathryn Shahwan, MD, FAAD

No financial relationships exist with ineligible companies.

Zain U. Syed, MD, FAAD

Castle Biosciences, Inc – Advisory Board(Honoraria), Speaker(Honoraria);

Junqian Zhang, MD, FAAD

No financial relationships exist with ineligible companies.